Irene Njuguna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Irene Njuguna has a total of 150 co-authors. Here are the top co-authors by number of shared publications:
Dalton Wamalwa
Department of Global Health, Medicine University of Washington, Seattle, WA
10 shared publicationsCyrus Mugo
Kenyatta National Hospital, Nairobi, Kenya
9 shared publicationsGrace John-Stewart
Department of Global Health, Medicine University of Washington, Seattle, WA
9 shared publicationsAlvin Onyango
Department of Pediatrics and Child Health, University of Nairobi, Nairobi, Kenya
7 shared publicationsAnjuli D. Wagner
Affiliation Department of Global Health, University of Washington, Seattle, Washington, United States of America
7 shared publications- Grace John-Stewart
Department of Global Health, University of Washington, Seattle, USA
7 shared publications
Latest Publications
- Open Access
An Fc receptor and IgA functional signature identifies TB disease in children living with HIV
Background: Tuberculosis (TB) is a leading cause of morbidity and mortality among children living with HIV (CLHIV). Poor diagnostic performance is a significant contributor. Serological assays that determine levels of Mycobacterium tuberculosis reactive antibodies inconsistently detect TB. However, antigen-specific antibody Fc receptor engagement and effector functions are promising biomarkers of TB disease. Methods: This study evaluated serum from a well-characterized cohort of Kenyan CLHIV via two orthogonal approaches: 1) longitudinally following over the course of TB treatment and 2) assessing a cross-section with and without clinical TB disease. For each individual sample, 13 antibody functional properties against 8 Mtb and 4 non- Mtb microbial antigens were measured and analyzed via univariate and multivariate machine-learning approaches. Findings: FcαR/CD89 immune complex formation with antibodies reactive to four Mtb antigens including ESAT-6 & CFP-10, FcψRI/CD64 associated with one Mtb antigen, and HIV gp120 IgA1 levels decreased during the intensive and continuation/consolidation phases of TB therapy. This antibody signature also highlighted treatment non-responsiveness and distinguished children with from those without TB disease with predictive capacity similar to Xpert. Interpretation: An Mtb and HIV reactive peripheral blood antibody functional signature of FcαR/CD89, FcψRI/CD64, and IgA1 has the potential to complement current clinical tools and those in development to diagnose pulmonary TB disease in CLHIV. Funding: This work is supported by UT Southwestern Disease Oriented Scholars Award (LLL), NIAID 5R01AI158858 (LLL), Burroughs-Wellcome Fund UTSW Training Resident Doctors as Innovators in Science (YJK), NICHD K12HD000850, NIAID K23AI143479 and R21AI192086 (LMC), NICHD R01 HD023412 (GJS), NIAID 75N93019C00071 (CW).
Open AccessAn Fc receptor and IgA functional signature identifies TB disease in children living with HIV
Background: Tuberculosis (TB) is a leading cause of morbidity and mortality among children living with HIV (CLHIV). Poor diagnostic performance is a significant contributor. Serological assays that determine levels of Mycobacterium tuberculosis reactive antibodies inconsistently detect TB. However, antigen-specific antibody Fc receptor engagement and effector functions are promising biomarkers of TB disease. Methods: This study evaluated serum from a well-characterized cohort of Kenyan CLHIV via two orthogonal approaches: 1) longitudinally following over the course of TB treatment and 2) assessing a cross-section with and without clinical TB disease. For each individual sample, 13 antibody functional properties against 8 Mtb and 4 non- Mtb microbial antigens were measured and analyzed via univariate and multivariate machine-learning approaches. Findings: FcαR/CD89 immune complex formation with antibodies reactive to four Mtb antigens including ESAT-6 & CFP-10, FcψRI/CD64 associated with one Mtb antigen, and HIV gp120 IgA1 levels decreased during the intensive and continuation/consolidation phases of TB therapy. This antibody signature also highlighted treatment non-responsiveness and distinguished children with from those without TB disease with predictive capacity similar to Xpert. Interpretation: An Mtb and HIV reactive peripheral blood antibody functional signature of FcαR/CD89, FcψRI/CD64, and IgA1 has the potential to complement current clinical tools and those in development to diagnose pulmonary TB disease in CLHIV. Funding: This work is supported by UT Southwestern Disease Oriented Scholars Award (LLL), NIAID 5R01AI158858 (LLL), Burroughs-Wellcome Fund UTSW Training Resident Doctors as Innovators in Science (YJK), NICHD K12HD000850, NIAID K23AI143479 and R21AI192086 (LMC), NICHD R01 HD023412 (GJS), NIAID 75N93019C00071 (CW).
- 1 December 2025
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 100 (4) , 331-335
Brief Report: Herpesvirus Viremia, ART Response, and Growth Recovery in Kenyan Children Starting Antiretroviral Therapy in Hospital
Background: We recently reported that cytomegalovirus (CMV) viremia was associated with worse clinical outcomes in hospitalized children starting antiretroviral therapy (ART). Here, we interrogate associations between CMV and Epstein–Barr (EBV) viremia and HIV viral suppression, CD4 recovery, and growth after ART initiation. Setting: In-patient setting, 4 hospitals in Kenya. Methods: We used regression models to assess associations between CMV and EBV viremia and 6-month growth and immunologic and virologic responses to ART in children aged 2 months to 12 years. Results: Overall, 142 (78%) of 181 children survived 6 months, of whom 94 (66%) had CMV and EBV DNA assessments pre-ART. Adjusting for baseline HIV RNA, children with baseline plasma CMV DNA ≥1000 IU//mL (coefficient=−5.65; 95% CI: −10.9 to −0.41, P = 0.035) and children with EBV DNA ≥1000 copies/mL had slower rates of CD4% increase (coefficient=−4.66; 95% CI: −7.06 to −2.27, P =<0.001). Age, WHO clinical stage, and stunting predicted growth recovery. Conclusions: High CMV or EBV viremia at admission predicted slower CD4 gain over 6 months in infants starting ART. These data suggest that herpesvirus viremia at baseline may identify a subset of children who will have a slower immunologic response to ART. Further research is needed to determine whether herpesvirus viremia delays ART responses and recovery in children.
- 1 December 2025
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 100 (4) , 331-335
Brief Report: Herpesvirus Viremia, ART Response, and Growth Recovery in Kenyan Children Starting Antiretroviral Therapy in Hospital
Background: We recently reported that cytomegalovirus (CMV) viremia was associated with worse clinical outcomes in hospitalized children starting antiretroviral therapy (ART). Here, we interrogate associations between CMV and Epstein–Barr (EBV) viremia and HIV viral suppression, CD4 recovery, and growth after ART initiation. Setting: In-patient setting, 4 hospitals in Kenya. Methods: We used regression models to assess associations between CMV and EBV viremia and 6-month growth and immunologic and virologic responses to ART in children aged 2 months to 12 years. Results: Overall, 142 (78%) of 181 children survived 6 months, of whom 94 (66%) had CMV and EBV DNA assessments pre-ART. Adjusting for baseline HIV RNA, children with baseline plasma CMV DNA ≥1000 IU//mL (coefficient=−5.65; 95% CI: −10.9 to −0.41, P = 0.035) and children with EBV DNA ≥1000 copies/mL had slower rates of CD4% increase (coefficient=−4.66; 95% CI: −7.06 to −2.27, P =<0.001). Age, WHO clinical stage, and stunting predicted growth recovery. Conclusions: High CMV or EBV viremia at admission predicted slower CD4 gain over 6 months in infants starting ART. These data suggest that herpesvirus viremia at baseline may identify a subset of children who will have a slower immunologic response to ART. Further research is needed to determine whether herpesvirus viremia delays ART responses and recovery in children.
- 26 September 2025
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 45 (2) , 170-172
Missed Opportunities to Prevent Mortality Among Youth Living With HIV: Insights From Verbal Autopsies and Clinical Record Reviews
We conducted verbal autopsies and abstracted medical records of deceased youth living with HIV to identify missed opportunities for intervention. Of 60 deceased youth, the median age was 20 years, 65% acquired HIV perinatally and 67% were female. Overall, 55% of deaths occurred in hospitals, and 74% had adherence challenges. Mental health challenges and viral failure were key contributors to mortality.
- 26 September 2025
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 45 (2) , 170-172
Missed Opportunities to Prevent Mortality Among Youth Living With HIV: Insights From Verbal Autopsies and Clinical Record Reviews
We conducted verbal autopsies and abstracted medical records of deceased youth living with HIV to identify missed opportunities for intervention. Of 60 deceased youth, the median age was 20 years, 65% acquired HIV perinatally and 67% were female. Overall, 55% of deaths occurred in hospitals, and 74% had adherence challenges. Mental health challenges and viral failure were key contributors to mortality.
- 1 July 2025
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 99 (3) , 229-238
“You Are the Tutor, You Are the Counselor, You Are the School Nurse, You Are Everything”: Secondary School Staff Experience With Youth Living With HIV
Background: Optimized treatment regimens have improved the survival of children/youth living with HIV (YLH) allowing them to pursue career goals. More YLH are now spending time in schools, but evidence points to adherence challenges in schools. We explored school staff experiences with YLH in the school environment. Methods: Four focus group discussions included 32 school staff from 32 high/secondary schools in Kenya. Inclusion criteria included having health responsibilities. Interview data were analyzed using directed content analysis. Results: The median age of participants was 35 (IQR: 31–45) years and over half were women (56%). The majority (91%) had both teaching and health roles, and half were staff at boarding schools. School staff reported YLH expressing feelings of hopelessness that resulted in medication nonadherence and demotivation to excel in school. Sometimes, YLH HIV status was only disclosed when YLH were referred for disciplinary action due to behavioral problems. Parent/caregiver psychological challenges and difficult home environments made it difficult for schools to work with families to support YLH. School staff often stepped in to offer psychological support to YLH, but this created significant time demands. School staff felt they were not adequately trained to provide the services that YLH needed and advocated for school-wide training on HIV and management of common psychological problems. Conclusions: To support YLH to achieve their full potential, there is a need to support school staff to gain the skills needed to support YLH health. Future work on addressing psychological and social health challenges in schools is warranted.
- 1 July 2025
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 99 (3) , 229-238
“You Are the Tutor, You Are the Counselor, You Are the School Nurse, You Are Everything”: Secondary School Staff Experience With Youth Living With HIV
Background: Optimized treatment regimens have improved the survival of children/youth living with HIV (YLH) allowing them to pursue career goals. More YLH are now spending time in schools, but evidence points to adherence challenges in schools. We explored school staff experiences with YLH in the school environment. Methods: Four focus group discussions included 32 school staff from 32 high/secondary schools in Kenya. Inclusion criteria included having health responsibilities. Interview data were analyzed using directed content analysis. Results: The median age of participants was 35 (IQR: 31–45) years and over half were women (56%). The majority (91%) had both teaching and health roles, and half were staff at boarding schools. School staff reported YLH expressing feelings of hopelessness that resulted in medication nonadherence and demotivation to excel in school. Sometimes, YLH HIV status was only disclosed when YLH were referred for disciplinary action due to behavioral problems. Parent/caregiver psychological challenges and difficult home environments made it difficult for schools to work with families to support YLH. School staff often stepped in to offer psychological support to YLH, but this created significant time demands. School staff felt they were not adequately trained to provide the services that YLH needed and advocated for school-wide training on HIV and management of common psychological problems. Conclusions: To support YLH to achieve their full potential, there is a need to support school staff to gain the skills needed to support YLH health. Future work on addressing psychological and social health challenges in schools is warranted.
- Open Access
- 20 June 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (6) , e0325374
Integration of a brief, transdiagnostic psychological intervention in the care of adolescents and young adults with HIV in Kenya: Protocol for a cluster randomized clinical trial
Adolescents and young adults with HIV (AYH) are at greater risk for mental health conditions. Provision of mental health services to AYH is limited by an overburdened and untrained workforce, and psychological interventions ill-adapted for adolescent HIV care. Brief, transdiagnostic psychological interventions delivered in the HIV clinics may address some of these challenges. We will evaluate the PRO-ACT intervention in a hybrid type 1 cluster randomized clinical trial (NCT06247527) in 30 HIV clinics in 3 counties in Kenya. PRO-ACT is a cognitive behavioral therapy with 5 modules: Psychoeducation, Relaxation, prOblem-solving, behavioral Activation and Cognitive coping, delivered to AYH by trained health providers without specialist mental health training in 4–6 sessions within 6 months. We performed stratified randomization with matching to balance for county and facility size to assign 5 intervention (PRO-ACT) and 5 control (standard of care) clinics in each of the 3 counties. Screening of AYH ages 16−24 years will be conducted using the 9-item patient health questionnaire (PHQ-9). Up to 300 AYH with psychological distress (PHQ-9 score>4) will be enrolled in each arm. Further assessments will include the 5-item ASK suicide screening questions (ASQ), 7-item Generalized Anxiety Disorder (GAD-7), 20-item Child and Adolescent Trauma Screen (CATS)/PTSD Checklist for DSM-5 (PCL-5), self-reported treatment adherence, and HIV viral loads. Follow-up assessments will be conducted at month 3, 6, 9 and 12. Mixed methods will be used to measure implementation outcomes, cost-effectiveness, and characterize determinants of implementation. Primary analysis of PRO-ACT effectiveness will be conducted at month 6 (near term treatment effect), and month 12 (treatment effect sustainability) comparing PHQ-9 mean scores between treatment and control groups. Secondary analyses will compare GAD-7, CATS/PCL-5, adherence and viral suppression between the groups. The study will inform integration efforts of holistic mental health services in HIV care.
- 20 June 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (6) , e0325374
Open AccessIntegration of a brief, transdiagnostic psychological intervention in the care of adolescents and young adults with HIV in Kenya: Protocol for a cluster randomized clinical trial
Adolescents and young adults with HIV (AYH) are at greater risk for mental health conditions. Provision of mental health services to AYH is limited by an overburdened and untrained workforce, and psychological interventions ill-adapted for adolescent HIV care. Brief, transdiagnostic psychological interventions delivered in the HIV clinics may address some of these challenges. We will evaluate the PRO-ACT intervention in a hybrid type 1 cluster randomized clinical trial (NCT06247527) in 30 HIV clinics in 3 counties in Kenya. PRO-ACT is a cognitive behavioral therapy with 5 modules: Psychoeducation, Relaxation, prOblem-solving, behavioral Activation and Cognitive coping, delivered to AYH by trained health providers without specialist mental health training in 4–6 sessions within 6 months. We performed stratified randomization with matching to balance for county and facility size to assign 5 intervention (PRO-ACT) and 5 control (standard of care) clinics in each of the 3 counties. Screening of AYH ages 16−24 years will be conducted using the 9-item patient health questionnaire (PHQ-9). Up to 300 AYH with psychological distress (PHQ-9 score>4) will be enrolled in each arm. Further assessments will include the 5-item ASK suicide screening questions (ASQ), 7-item Generalized Anxiety Disorder (GAD-7), 20-item Child and Adolescent Trauma Screen (CATS)/PTSD Checklist for DSM-5 (PCL-5), self-reported treatment adherence, and HIV viral loads. Follow-up assessments will be conducted at month 3, 6, 9 and 12. Mixed methods will be used to measure implementation outcomes, cost-effectiveness, and characterize determinants of implementation. Primary analysis of PRO-ACT effectiveness will be conducted at month 6 (near term treatment effect), and month 12 (treatment effect sustainability) comparing PHQ-9 mean scores between treatment and control groups. Secondary analyses will compare GAD-7, CATS/PCL-5, adherence and viral suppression between the groups. The study will inform integration efforts of holistic mental health services in HIV care.
- Open Access
Cohort profile: longitudinal and population comparison of children who are HIV-exposed uninfected and children who are HIV unexposed in Kenya (HOPE study)
Purpose Globally, the number of children/adolescents exposed to HIV but uninfected (HIV-exposed uninfected, HEU) is growing. The HEU outcomes: population-evaluation and screening strategies study was designed to provide population-level evidence of the impact of HIV and recent antiretroviral therapy regimen exposure on neurodevelopmental, hearing and mental health outcomes from infancy to adolescence. Participants The study includes a prospective mother–infant cohort and cross-sectional child/youth–caregiver cohorts conducted in Kenya. Between 2021 and 2022, the study enrolled 2000 mother–infant pairs (1000 HEU and 1000 HIV-unexposed uninfected (HUU)) for longitudinal follow-up. Infants were eligible if they were aged 4–10 weeks and healthy. Mothers were eligible if their HIV status was known and were ≥18 years. Study visits are 6 monthly until the child reaches age 3 years. Cross-sectional cohorts spanning ages 3–18 years started enrolment in 2022. Target enrolment is 4400 children/youth (4000 HEU and 400 HUU). Children and youth are eligible if they are HIV negative, maternal HIV status and timing of diagnosis is known, and caregivers are ≥18 years. Data on infant/child/youth growth, neurodevelopment, mental health, morbidity and hearing are collected at enrolment using standardised tools. Dry blood spots samples are collected for telomere length assessment at baseline and yearly for the longitudinal cohort. Growth z-scores, neurodevelopmental scores, telomere length and prevalence of developmental and hearing problems will be compared between HEU/HUU populations. Findings to date Full cohort enrolment for the longitudinal cohort is complete and participants are in follow-up. At 1 year of age, comparing HEU to HUU neurodevelopment using the Malawi developmental assessment tool, we found that HEU infants had higher language scores and comparable scores in fine motor, gross motor and social scores. The cross-sectional cohort has enrolled over 2000 participants and recruitment is ongoing. Future plans Longitudinal cohort follow-up and enrolment to the cross-sectional study will be completed in June 2024.
Open AccessCohort profile: longitudinal and population comparison of children who are HIV-exposed uninfected and children who are HIV unexposed in Kenya (HOPE study)
Purpose Globally, the number of children/adolescents exposed to HIV but uninfected (HIV-exposed uninfected, HEU) is growing. The HEU outcomes: population-evaluation and screening strategies study was designed to provide population-level evidence of the impact of HIV and recent antiretroviral therapy regimen exposure on neurodevelopmental, hearing and mental health outcomes from infancy to adolescence. Participants The study includes a prospective mother–infant cohort and cross-sectional child/youth–caregiver cohorts conducted in Kenya. Between 2021 and 2022, the study enrolled 2000 mother–infant pairs (1000 HEU and 1000 HIV-unexposed uninfected (HUU)) for longitudinal follow-up. Infants were eligible if they were aged 4–10 weeks and healthy. Mothers were eligible if their HIV status was known and were ≥18 years. Study visits are 6 monthly until the child reaches age 3 years. Cross-sectional cohorts spanning ages 3–18 years started enrolment in 2022. Target enrolment is 4400 children/youth (4000 HEU and 400 HUU). Children and youth are eligible if they are HIV negative, maternal HIV status and timing of diagnosis is known, and caregivers are ≥18 years. Data on infant/child/youth growth, neurodevelopment, mental health, morbidity and hearing are collected at enrolment using standardised tools. Dry blood spots samples are collected for telomere length assessment at baseline and yearly for the longitudinal cohort. Growth z-scores, neurodevelopmental scores, telomere length and prevalence of developmental and hearing problems will be compared between HEU/HUU populations. Findings to date Full cohort enrolment for the longitudinal cohort is complete and participants are in follow-up. At 1 year of age, comparing HEU to HUU neurodevelopment using the Malawi developmental assessment tool, we found that HEU infants had higher language scores and comparable scores in fine motor, gross motor and social scores. The cross-sectional cohort has enrolled over 2000 participants and recruitment is ongoing. Future plans Longitudinal cohort follow-up and enrolment to the cross-sectional study will be completed in June 2024.
- Open Access
- 16 April 2024
- Published by Frontiers Media SA in Frontiers in Reproductive Health
- Vol. 6, 1382548
Editorial: Improving the delivery of pre-exposure prophylaxis (PrEP) to eliminate vertical HIV transmission
Editorial: Improving the delivery of pre-exposure prophylaxis (PrEP) to eliminate vertical HIV transmission
- 16 April 2024
- Published by Frontiers Media SA in Frontiers in Reproductive Health
- Vol. 6, 1382548
Open AccessEditorial: Improving the delivery of pre-exposure prophylaxis (PrEP) to eliminate vertical HIV transmission
Editorial: Improving the delivery of pre-exposure prophylaxis (PrEP) to eliminate vertical HIV transmission
- Open Access
- 5 February 2024
- Published by Ubiquity Press, Ltd. in Annals of Global Health
- Vol. 90 (1) , 10
Hearing Loss Detection and Early Intervention Strategies in Kenya
Annals of Global Health is a peer-reviewed, fully open access, online journal dedicated to publishing high quality articles dedicated to all aspects of global health. The journal's mission is to advance global health, promote research, and foster the prevention and treatment of disease worldwide. Its goals are to improve the health and well-being of all people, advance health equity, and promote wise stewardship of the earth's environment. The latest journal impact factor is 2.90. Annals of Global Health is supported by the Program for Global Public Health and the Common Good at Boston College. It was founded in 1934 by the Icahn School of Medicine at Mount Sinai as the Mount Sinai Journal of Medicine. It is a partner journal of the Consortium of Universities for Global Health. From time to time, Annals of Global Health publishes Special Collections, a series of articles organized around a common theme in global health. Recent Special Collections have included "Local evidence and strategies in addressing NCDs Non-Communicable Diseases in Tanzania", "Universal Health Coverage through Integrated Care", and "The Minderoo-Monaco Commission on Plastics and Human Health". Global health workers interested in developing a Special Collection are strongly encouraged to contact the Managing Editor in advance to discuss the project.
- 5 February 2024
- Published by Ubiquity Press, Ltd. in Annals of Global Health
- Vol. 90 (1) , 10
Open AccessHearing Loss Detection and Early Intervention Strategies in Kenya
Annals of Global Health is a peer-reviewed, fully open access, online journal dedicated to publishing high quality articles dedicated to all aspects of global health. The journal's mission is to advance global health, promote research, and foster the prevention and treatment of disease worldwide. Its goals are to improve the health and well-being of all people, advance health equity, and promote wise stewardship of the earth's environment. The latest journal impact factor is 2.90. Annals of Global Health is supported by the Program for Global Public Health and the Common Good at Boston College. It was founded in 1934 by the Icahn School of Medicine at Mount Sinai as the Mount Sinai Journal of Medicine. It is a partner journal of the Consortium of Universities for Global Health. From time to time, Annals of Global Health publishes Special Collections, a series of articles organized around a common theme in global health. Recent Special Collections have included "Local evidence and strategies in addressing NCDs Non-Communicable Diseases in Tanzania", "Universal Health Coverage through Integrated Care", and "The Minderoo-Monaco Commission on Plastics and Human Health". Global health workers interested in developing a Special Collection are strongly encouraged to contact the Managing Editor in advance to discuss the project.
- 2 November 2023
- Published by Wiley in Journal of School Health
- Vol. 94 (2) , 178-183
Gaps and Opportunities for Strengthening In‐School Support for Youth Living With HIV
Objectives: With optimized antiretroviral treatment youth living with HIV (YLH) now spend most of their time in schools, making schools an important venue to optimize outcomes. We evaluated school support for YLH.Methods: We conducted surveys with public secondary/high schools in 3 Kenyan counties (Nairobi, Homa Bay, and Kajiado) to determine policies and training related to HIV. Chi-squared tests and Poisson regression were used to compare policy availability and staff training by county HIV prevalence and school type.Results: Of 512 schools in the 3 counties, we surveyed 100. The majority (60%) of schools surveyed had boarding facilities. The median student population was 406 (IQR: 200, 775). Only half (49%) of schools had medication use policies; more in boarding than day schools (65% vs 30%, p = .003). While most schools (82%) had clinic attendance policies; policy availability was higher in higher HIV prevalence counties (Homa Bay [100%], Nairobi [82%], Kajiado [56%], p < .05). Overall, 64% had confidentiality policies with higher policy availability in higher HIV prevalence regions (p < .05). Few schools had staff trained in HIV-related topics: HIV prevention (37%), HIV treatment (18%), HIV stigma reduction (36%). Few were trained in confidentiality (41%), psychosocial support (40%), or mental health (26%). Compared to day schools, boarding school were more likely to have staff trained in HIV prevention (prevalence ratio: 2.1 [95% confidence interval 1.0, 4.0], p = .037).Conclusion: In this survey of Kenyan schools, there were notable gaps in HIV care policy availability and training, despite high HIV burden. Development and implementation of national school HIV policies and staff training as well as strengthening clinic and family support may improve outcomes for YLH.
- 2 November 2023
- Published by Wiley in Journal of School Health
- Vol. 94 (2) , 178-183
Gaps and Opportunities for Strengthening In‐School Support for Youth Living With HIV
Objectives: With optimized antiretroviral treatment youth living with HIV (YLH) now spend most of their time in schools, making schools an important venue to optimize outcomes. We evaluated school support for YLH.Methods: We conducted surveys with public secondary/high schools in 3 Kenyan counties (Nairobi, Homa Bay, and Kajiado) to determine policies and training related to HIV. Chi-squared tests and Poisson regression were used to compare policy availability and staff training by county HIV prevalence and school type.Results: Of 512 schools in the 3 counties, we surveyed 100. The majority (60%) of schools surveyed had boarding facilities. The median student population was 406 (IQR: 200, 775). Only half (49%) of schools had medication use policies; more in boarding than day schools (65% vs 30%, p = .003). While most schools (82%) had clinic attendance policies; policy availability was higher in higher HIV prevalence counties (Homa Bay [100%], Nairobi [82%], Kajiado [56%], p < .05). Overall, 64% had confidentiality policies with higher policy availability in higher HIV prevalence regions (p < .05). Few schools had staff trained in HIV-related topics: HIV prevention (37%), HIV treatment (18%), HIV stigma reduction (36%). Few were trained in confidentiality (41%), psychosocial support (40%), or mental health (26%). Compared to day schools, boarding school were more likely to have staff trained in HIV prevention (prevalence ratio: 2.1 [95% confidence interval 1.0, 4.0], p = .037).Conclusion: In this survey of Kenyan schools, there were notable gaps in HIV care policy availability and training, despite high HIV burden. Development and implementation of national school HIV policies and staff training as well as strengthening clinic and family support may improve outcomes for YLH.
- Open Access
- 1 October 2023
- Published by Wiley in Journal of the International AIDS Society
- Vol. 26 (S4) , e26149
Neurodevelopment of children who are HIV‐exposed and uninfected in Kenya
Introduction: Predictors of neurodevelopment among children who are HIV‐exposed uninfected (CHEU) are poorly understood.Methods: Mothers with and without HIV and their children were enrolled during 6‐week postnatal care visits across seven sites in Kenya between March 2021 and June 2022. Infant neurodevelopment was assessed using the Malawi Developmental Assessment Tool, including social, language, fine motor and gross motor domains. We used multivariate linear mixed effects models to identify associations between 1‐year neurodevelopment scores, HIV and antiretroviral therapy (ART) exposures, and household factors, adjusted for potential confounders and clustered by the site.Results: At 1‐year evaluation, CHEU (n = 709) and children who are HIV‐unexposed uninfected (CHUU) (n = 715) had comparable median age (52 weeks) and sex distribution (49% vs. 52% female). Mothers living with HIV were older (31 vs. 27 years), had lower education (50% vs. 26% primary) and were more likely to be report moderate‐to‐severe food insecurity (26% vs. 9%) (p < 0.01 for all). Compared to CHUU, CHEU had higher language scores (adjusted coeff: 0.23, 95% CI: 0.06, 0.39) and comparable social, fine and gross motor scores. Among all children, preterm birth was associated with lower gross motor scores (adjusted coeff: −1.38, 95% CI: −2.05, −0.71), food insecurity was associated with lower social scores (adjusted coeff: −0.37, 95% CI: −0.73, −0.01) and maternal report of intimate partner violence (IPV) was associated with lower fine motor (adjusted coeff: −0.76, 95% CI: −1.40, −0.13) and gross motor scores (adjusted coeff: −1.07, 95% CI: −1.81, −0.33). Among CHEU, in utero efavirenz (EFV) exposure during pregnancy was associated with lower gross motor scores compared to dolutegravir (DTG) exposure (adjusted coeff: −0.51, 95% CI: −1.01, −0.03). Lower fine and gross motor scores were also associated with having a single or widowed mother (adjusted coeff: −0.45, 95% CI: −0.87, −0.03) or a deceased or absent father (adjusted coeff: −0.81, 95% CI: −1.58, −0.05), respectively.Conclusions: Biologic and social factors were associated with child neurodevelopment. Despite socio‐demographic differences between CHEU and CHUU, 1‐year neurodevelopment was similar. Addressing IPV and food insecurity may provide benefits regardless of maternal HIV status. DTG use was associated with higher neurodevelopmental scores in CHEU, compared to EFV regimens, potentially contributing to a lack of neurodevelopmental difference between CHEU and CHUU.
- 1 October 2023
- Published by Wiley in Journal of the International AIDS Society
- Vol. 26 (S4) , e26149
Open AccessNeurodevelopment of children who are HIV‐exposed and uninfected in Kenya
Introduction: Predictors of neurodevelopment among children who are HIV‐exposed uninfected (CHEU) are poorly understood.Methods: Mothers with and without HIV and their children were enrolled during 6‐week postnatal care visits across seven sites in Kenya between March 2021 and June 2022. Infant neurodevelopment was assessed using the Malawi Developmental Assessment Tool, including social, language, fine motor and gross motor domains. We used multivariate linear mixed effects models to identify associations between 1‐year neurodevelopment scores, HIV and antiretroviral therapy (ART) exposures, and household factors, adjusted for potential confounders and clustered by the site.Results: At 1‐year evaluation, CHEU (n = 709) and children who are HIV‐unexposed uninfected (CHUU) (n = 715) had comparable median age (52 weeks) and sex distribution (49% vs. 52% female). Mothers living with HIV were older (31 vs. 27 years), had lower education (50% vs. 26% primary) and were more likely to be report moderate‐to‐severe food insecurity (26% vs. 9%) (p < 0.01 for all). Compared to CHUU, CHEU had higher language scores (adjusted coeff: 0.23, 95% CI: 0.06, 0.39) and comparable social, fine and gross motor scores. Among all children, preterm birth was associated with lower gross motor scores (adjusted coeff: −1.38, 95% CI: −2.05, −0.71), food insecurity was associated with lower social scores (adjusted coeff: −0.37, 95% CI: −0.73, −0.01) and maternal report of intimate partner violence (IPV) was associated with lower fine motor (adjusted coeff: −0.76, 95% CI: −1.40, −0.13) and gross motor scores (adjusted coeff: −1.07, 95% CI: −1.81, −0.33). Among CHEU, in utero efavirenz (EFV) exposure during pregnancy was associated with lower gross motor scores compared to dolutegravir (DTG) exposure (adjusted coeff: −0.51, 95% CI: −1.01, −0.03). Lower fine and gross motor scores were also associated with having a single or widowed mother (adjusted coeff: −0.45, 95% CI: −0.87, −0.03) or a deceased or absent father (adjusted coeff: −0.81, 95% CI: −1.58, −0.05), respectively.Conclusions: Biologic and social factors were associated with child neurodevelopment. Despite socio‐demographic differences between CHEU and CHUU, 1‐year neurodevelopment was similar. Addressing IPV and food insecurity may provide benefits regardless of maternal HIV status. DTG use was associated with higher neurodevelopmental scores in CHEU, compared to EFV regimens, potentially contributing to a lack of neurodevelopmental difference between CHEU and CHUU.